Cargando…
Plasma Biosignature and Brain Pathology related to Persistent Cognitive Impairment in Late-Life Depression
Cognitive impairment is highly prevalent among individuals with late-life depression (LLD) and tends to persist even after successful treatment. The biological mechanisms underlying cognitive impairment in LLD are complex and likely involve abnormalities in multiple pathways, or “cascades,” reflecte...
Autores principales: | Diniz, Breno S., Sibille, Etienne, Ding, Ying, Tseng, George, Aizenstein, Howard, Lotrich, Francis, Becker, James T., Lopez, Oscar L., Lotze, Michael T., Klunk, William E., Reynolds, Charles F., Butters, Meryl A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494754/ https://www.ncbi.nlm.nih.gov/pubmed/25092249 http://dx.doi.org/10.1038/mp.2014.76 |
Ejemplares similares
-
Pathways linking late-life depression to persistent cognitive impairment and dementia
por: Butters, Meryl A., et al.
Publicado: (2008) -
Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression
por: Karim, Helmet T., et al.
Publicado: (2018) -
Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome
por: Diniz, Breno S., et al.
Publicado: (2022) -
Late-life depression and increased risk of dementia: a longitudinal cohort study
por: Ly, M., et al.
Publicado: (2021) -
Exoplanet Biosignatures: Understanding Oxygen as a Biosignature in the Context of Its Environment
por: Meadows, Victoria S., et al.
Publicado: (2018)